Aeluma, IncAeluma secured a $30M non-dilutive CHIPS R&D LOI and holds $56M cash with no debt, funding its AI datacom commercialization.
Aeluma Inc is shifting its near-term commercialization focus to the AI datacom market, backed by a letter of intent with the Department of Commerce CHIPS R&D Office for up to $30 million in non-dilutive funding. The company ended fiscal 2026 with $56 million in cash and no debt, but reported a net loss of $9.2 million, wider than the $3 million loss in fiscal 2025, and adjusted EBITDA of negative $5.2 million versus positive $186,000 a year earlier. Aeluma expects government contract revenue to fall to approximately $2.3 million in fiscal 2027 from $4.5 million in fiscal 2026, while planning capital expenditures of $10 million to $12 million, mainly for two Aixtron G10 MOCVD reactors. The company strengthened its manufacturing partnership with Sumitomo Chemical Advanced Technologies and is negotiating commercial NRE agreements, though no deals are guaranteed. Management said the CHIPS award, if finalized, would likely be accounted for as an equity investment by the U.S. government rather than revenue.
Aeluma, IncAeluma secured a $30M non-dilutive CHIPS R&D LOI and holds $56M cash with no debt, funding its AI datacom commercialization.
AIXTRON SEAeluma plans $10-12M capex mainly for two Aixtron G10 MOCVD reactors, representing concrete equipment orders for Aixtron.
Aeluma strengthened its manufacturing partnership with Sumitomo Chemical Advanced Technologies.